Status | Study |
Active, not recruiting |
Study Name: Bexsero™and Routine Infant Vaccines: Effect of Coadministration on the Safety of Immunization Condition: Meningococcal Infections Date: 2016-03-14 Interventions: Biological: 4CMenb Other Name: |
Active, not recruiting |
Study Name: Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba) Condition: Meningococcal Infections Date: 2015-09-30 Interventions: Biological: Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals) All subjects will receive three doses of a T |
Completed |
Study Name: A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years Condition: MENINGOCOCCAL INFECTION Date: 2015-08-20 Interventions: Biological: Bivalent rLP2086 Vaccine |
Completed |
Study Name: Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects. Condition: Meningococcal Disease Date: 2014-05-15 Interventions: Biological: rMenB+OMV 2 doses of vaccine 2 months apart |
Active, not recruiting |
Study Name: MenPF-1 - A New Vaccine Against Meningococcal Disease Condition: Serogroup B Meningococcal Disease Date: 2012-05-23 Interventions: Biological: MenPF-1. A new vaccine against meningococcal disease. |
Recruiting |
Study Name: Duration of Immunity Study Condition: Meningococcal Infection Date: 2012-02-17 Interventions: Procedure: blood sampling Bloo |
Completed |
Study Name: Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers Condition: Meningococcal Infection Date: 2011-04-14 Interventions: Biological: Meningococcal vaccine GSK 134612 |
Completed |
Study Name: Regulation of Mucosal Immune Response to Systemic MenB Vaccine Condition: Meningococcal Infections Date: 2008-10-16 Interventions: Biological: NZ MenB OMV vaccine (NZ98/254) 3 doses by intramuscular injection |
Completed |
Study Name: Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules Condition: Meningococcal Infections Date: 2008-07-22 Interventions: Biological: rMenB+OMV NZ Biological: combi |
Completed |
Study Name: Group B Meningococcal Vaccine Condition: Meningococcal Infection, Group B Date: 2008-05-08 Interventions: Biological: Group B Meningococcal 8570 HOPS-G NOMV Vaccine |